Log in
Enquire now
‌

US Patent 10689449 Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
IGM Biosciences
IGM Biosciences
Current Assignee
IGM Biosciences
IGM Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10689449
Date of Patent
June 23, 2020
Patent Application Number
15544873
Date Filed
January 20, 2016
Patent Citations
‌
US Patent 10604559 Multi-valent hepatitis B virus antigen binding molecules and uses thereof
‌
US Patent 10351631 Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies
‌
US Patent 10400038 Modified J-chain
‌
US Patent 10618978 Binding molecules with modified J-chain
Patent Citations Received
‌
US Patent 11639389 Binding molecules with modified J-chain
0
‌
US Patent 11542342 Binding molecules with modified J-chain
‌
US Patent 11555075 Modified J-chain
‌
US Patent 11578131 Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules
‌
US Patent 10822399 IgA multi-specific binding molecules
‌
US Patent 10899835 IgM Fc and J-chain mutations that affect IgM serum half-life
‌
US Patent 10954302 Anti-PD-L1 antibodies
‌
US Patent 10975147 Modified J-chain
...
Patent Primary Examiner
‌
Robert S. Landsman
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10689449 Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.